Want to see HEWA full AI Analyst Report?
HEWA Stock Chart & Stats
$0.12
<$0.01(0.61%)
At close: 4:00 PM EST
$0.12
<$0.01(0.61%)
Day’s Range― - ―
52-Week Range$0.08 - $0.18
Previous CloseN/A
Volume49.90K
Average Volume (3M)2.08K
Market Cap
$7.43M
Enterprise Value$8.47M
Total Cash (Recent Filing)$1.46M
Total Debt (Recent Filing)$3.54M
Price to Earnings (P/E)―
Beta-0.39
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding57,190,910
10 Day Avg. Volume2,307
30 Day Avg. Volume2,084
Financial Highlights & Ratios
PEG Ratio0.89
Price to Book (P/B)-1.88
Price to Sales (P/S)0.13
P/FCF Ratio5.83
Enterprise Value/Market Cap1.14
Enterprise Value/Revenue0.21
Enterprise Value/Gross Profit0.53
Enterprise Value/Ebitda22.32
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Direct-to-Consumer Mail-Order ModelThe company’s DTC mail-order pharmacy model creates durable recurring revenue from prescription refills and convenience-driven demand. Lower physical-store overhead and direct customer relationships support unit economics, customer retention, and scalable distribution over a multi-month horizon.
Sustained Gross MarginA ~39% gross margin provides a structural cushion to absorb SG&A and funding variability. Sustained gross profitability supports margin recovery if volumes rebound, enabling reinvestment in customer acquisition, fulfillment efficiencies, or product expansion without immediate reliance on external capital.
Historical Revenue Scaling And Prior ProfitabilityThe company demonstrated the ability to scale revenue over several years and reached small-profitability in 2025, indicating operational leverage. This history shows the business can convert scale to operating profits when demand and execution align, supporting mid-term recovery prospects.
Bears Say
Negative Stockholders' EquityNegative stockholders’ equity is a material, durable constraint on financial flexibility. It raises refinancing and going-concern sensitivity, elevates perceived leverage even with moderate debt, and can limit access to capital, supplier terms, and strategic options over the next several months.
Recent Cash Flow BurnSharp TTM cash burn signals working-capital or funding stress and creates near-term liquidity risk. Persistent negative free cash flow forces reliance on external financing or asset draws, constraining investments in growth, fulfillment scale, or margin-improving initiatives over the medium term.
Declining Recent Revenue And Reversion To LossA ~17.7% TTM revenue decline and renewed net loss indicate demand softness and volatile earnings quality. This weakens margin sustainability and cash generation, increasing execution risk as the company must restore volumes or pricing while managing constrained capital and competitive pressures.
HEWA FAQ
What was HealthWarehouse.com Inc’s price range in the past 12 months?
HealthWarehouse.com Inc lowest stock price was $0.08 and its highest was $0.18 in the past 12 months.
What is HealthWarehouse.com Inc’s market cap?
HealthWarehouse.com Inc’s market cap is $7.43M.
When is HealthWarehouse.com Inc’s upcoming earnings report date?
HealthWarehouse.com Inc’s upcoming earnings report date is Aug 06, 2026 which is in 35 days.
How were HealthWarehouse.com Inc’s earnings last quarter?
HealthWarehouse.com Inc released its earnings results on May 11, 2026. The company reported -$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.008.
Is HealthWarehouse.com Inc overvalued?
According to Wall Street analysts HealthWarehouse.com Inc’s price is currently Overvalued.
Does HealthWarehouse.com Inc pay dividends?
HealthWarehouse.com Inc does not currently pay dividends.
What is HealthWarehouse.com Inc’s EPS estimate?
HealthWarehouse.com Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HealthWarehouse.com Inc have?
HealthWarehouse.com Inc has 57,190,910 shares outstanding.
What happened to HealthWarehouse.com Inc’s price movement after its last earnings report?
HealthWarehouse.com Inc reported an EPS of -$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -13.907%.
Which hedge fund is a major shareholder of HealthWarehouse.com Inc?
Currently, no hedge funds are holding shares in HEWA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
HealthWarehouse.com Inc
HealthWarehouse.com, Inc. functions as a digital and direct-mail pharmaceutical service. Its offerings encompass a broad spectrum of pharmaceutical items, including generic and brand-name prescription drugs, specialized medications for pets, and a variety of over-the-counter remedies and goods. The company serves customers across all 50 U.S. states and the District of Columbia, specifically targeting the market for prescription drugs paid for directly by consumers. Sales are conducted directly to individual consumers via its online platform. Its corporate headquarters are situated in Florence, Kentucky.
Technical Analysis
Petmed Express
―
ENDRA Life Sciences
―
LifeMD
―
Pasithea Therapeutics Corp
―
Heart Test Laboratories, Inc.
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---